Daniela Calandrella

Euro<scp>I</scp>nf: <scp>A</scp><scp>M</scp>ulticenter <scp>C</scp>omparative <scp>O</scp>bservational <scp>S</scp>tudy of <scp>A</scp>pomorphine and <scp>L</scp>evodopa <scp>I</scp>nfusion in <scp>P</scp>arkinson's <scp>D</scp>isease

Pablo Martínez‐Martín, Prashanth Reddy, Regina Katzenschlager et al. · Movement Disorders · 2014 · 243 citations

Medicine, Pharmacology, Pharmacotherapy +11

Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo‐controlled study

Roberta Zangaglia, E. Martignoni, Margaret Glorioso et al. · Movement Disorders · 2007 · 173 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Comorbid disorders and hospitalisation in Parkinson?s disease: a prospective study

E. Martignoni, L. Godi, A. Citterio et al. · Neurological Sciences · 2004 · 89 citations

Life Sciences, Neurology, Neuroscience +12

Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens

Francesca Mancini, Cristoforo Comi, Gaia Donata Oggioni et al. · Parkinsonism & Related Disorders · 2013 · 89 citations · Full text

Medicine, Neurology, Pharmacology +16

Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson?s disease. The effect of dopaminergic treatment

Fabio Blandini, Marco Cosentino, Anna Mangiagalli et al. · Journal of Neural Transmission · 2004 · 68 citations

Life Sciences, Cell Biology, Neuroscience +15